Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Cash from Investing Activities (2020 - 2023)

Terns Pharmaceuticals' Cash from Investing Activities history spans 4 years, with the latest figure at $47.2 million for Q4 2023.

  • For Q4 2023, Cash from Investing Activities rose 424.71% year-over-year to $47.2 million; the TTM value through Dec 2023 reached -$38.0 million, down 70.56%, while the annual FY2025 figure was -$298.0 million, 2301.64% down from the prior year.
  • Cash from Investing Activities reached $47.2 million in Q4 2023 per TERN's latest filing, up from -$22.3 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $47.2 million in Q4 2023 to a low of -$96.8 million in Q1 2021.
  • Average Cash from Investing Activities over 4 years is -$10.8 million, with a median of -$671000.0 recorded in 2020.
  • The largest YoY upside for Cash from Investing Activities was 88960.0% in 2021 against a maximum downside of 20392.16% in 2021.
  • A 4-year view of Cash from Investing Activities shows it stood at -$47000.0 in 2020, then tumbled by 13561.7% to -$6.4 million in 2021, then crashed by 126.54% to -$14.5 million in 2022, then surged by 424.71% to $47.2 million in 2023.
  • Per Business Quant, the three most recent readings for TERN's Cash from Investing Activities are $47.2 million (Q4 2023), -$22.3 million (Q3 2023), and -$90.8 million (Q2 2023).